Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: Q4Q980
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009451 | RNA modification | 5 | 2 |
GO:0009892 | negative regulation of metabolic process | 4 | 2 |
GO:0009893 | positive regulation of metabolic process | 4 | 2 |
GO:0009894 | regulation of catabolic process | 4 | 2 |
GO:0009895 | negative regulation of catabolic process | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0010468 | regulation of gene expression | 5 | 2 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 2 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 2 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 2 |
GO:0010628 | positive regulation of gene expression | 6 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016553 | base conversion or substitution editing | 6 | 2 |
GO:0016554 | cytidine to uridine editing | 7 | 2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 2 |
GO:0019222 | regulation of metabolic process | 3 | 2 |
GO:0031323 | regulation of cellular metabolic process | 4 | 2 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 2 |
GO:0031329 | regulation of cellular catabolic process | 5 | 2 |
GO:0031330 | negative regulation of cellular catabolic process | 6 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043487 | regulation of RNA stability | 3 | 2 |
GO:0043488 | regulation of mRNA stability | 4 | 2 |
GO:0043489 | RNA stabilization | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0048255 | mRNA stabilization | 5 | 2 |
GO:0048518 | positive regulation of biological process | 3 | 2 |
GO:0048519 | negative regulation of biological process | 3 | 2 |
GO:0048523 | negative regulation of cellular process | 4 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 2 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 2 |
GO:0051252 | regulation of RNA metabolic process | 5 | 2 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 2 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 2 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0065008 | regulation of biological quality | 2 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0080090 | regulation of primary metabolic process | 4 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1902369 | negative regulation of RNA catabolic process | 7 | 2 |
GO:1902373 | negative regulation of mRNA catabolic process | 7 | 2 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 2 |
GO:1903312 | negative regulation of mRNA metabolic process | 7 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 192 | 194 | PF00675 | 0.357 |
CLV_NRD_NRD_1 | 225 | 227 | PF00675 | 0.351 |
CLV_NRD_NRD_1 | 286 | 288 | PF00675 | 0.436 |
CLV_NRD_NRD_1 | 297 | 299 | PF00675 | 0.369 |
CLV_NRD_NRD_1 | 306 | 308 | PF00675 | 0.391 |
CLV_NRD_NRD_1 | 363 | 365 | PF00675 | 0.345 |
CLV_NRD_NRD_1 | 61 | 63 | PF00675 | 0.655 |
CLV_PCSK_KEX2_1 | 192 | 194 | PF00082 | 0.357 |
CLV_PCSK_KEX2_1 | 225 | 227 | PF00082 | 0.351 |
CLV_PCSK_KEX2_1 | 286 | 288 | PF00082 | 0.449 |
CLV_PCSK_KEX2_1 | 297 | 299 | PF00082 | 0.291 |
CLV_PCSK_KEX2_1 | 306 | 308 | PF00082 | 0.391 |
CLV_PCSK_KEX2_1 | 492 | 494 | PF00082 | 0.453 |
CLV_PCSK_KEX2_1 | 61 | 63 | PF00082 | 0.629 |
CLV_PCSK_PC1ET2_1 | 492 | 494 | PF00082 | 0.453 |
CLV_PCSK_SKI1_1 | 163 | 167 | PF00082 | 0.530 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.369 |
CLV_PCSK_SKI1_1 | 260 | 264 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 281 | 285 | PF00082 | 0.386 |
CLV_PCSK_SKI1_1 | 298 | 302 | PF00082 | 0.354 |
CLV_PCSK_SKI1_1 | 411 | 415 | PF00082 | 0.652 |
CLV_PCSK_SKI1_1 | 495 | 499 | PF00082 | 0.413 |
CLV_Separin_Metazoa | 222 | 226 | PF03568 | 0.367 |
DEG_APCC_DBOX_1 | 297 | 305 | PF00400 | 0.343 |
DEG_APCC_DBOX_1 | 419 | 427 | PF00400 | 0.403 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.620 |
DEG_SPOP_SBC_1 | 39 | 43 | PF00917 | 0.712 |
DOC_CKS1_1 | 211 | 216 | PF01111 | 0.390 |
DOC_CYCLIN_RxL_1 | 257 | 268 | PF00134 | 0.494 |
DOC_MAPK_gen_1 | 364 | 371 | PF00069 | 0.351 |
DOC_MAPK_HePTP_8 | 467 | 479 | PF00069 | 0.464 |
DOC_MAPK_MEF2A_6 | 364 | 373 | PF00069 | 0.367 |
DOC_MAPK_MEF2A_6 | 470 | 479 | PF00069 | 0.510 |
DOC_PP2B_LxvP_1 | 109 | 112 | PF13499 | 0.556 |
DOC_PP4_FxxP_1 | 315 | 318 | PF00568 | 0.358 |
DOC_PP4_MxPP_1 | 332 | 335 | PF00568 | 0.493 |
DOC_USP7_MATH_1 | 24 | 28 | PF00917 | 0.684 |
DOC_USP7_MATH_1 | 336 | 340 | PF00917 | 0.512 |
DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.760 |
DOC_USP7_MATH_1 | 460 | 464 | PF00917 | 0.392 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.587 |
DOC_USP7_UBL2_3 | 525 | 529 | PF12436 | 0.516 |
DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.451 |
DOC_WW_Pin1_4 | 20 | 25 | PF00397 | 0.709 |
DOC_WW_Pin1_4 | 210 | 215 | PF00397 | 0.403 |
DOC_WW_Pin1_4 | 330 | 335 | PF00397 | 0.381 |
DOC_WW_Pin1_4 | 349 | 354 | PF00397 | 0.363 |
DOC_WW_Pin1_4 | 65 | 70 | PF00397 | 0.688 |
DOC_WW_Pin1_4 | 96 | 101 | PF00397 | 0.590 |
LIG_14-3-3_CanoR_1 | 17 | 25 | PF00244 | 0.715 |
LIG_14-3-3_CanoR_1 | 192 | 196 | PF00244 | 0.358 |
LIG_14-3-3_CanoR_1 | 217 | 222 | PF00244 | 0.364 |
LIG_14-3-3_CanoR_1 | 380 | 387 | PF00244 | 0.334 |
LIG_14-3-3_CanoR_1 | 495 | 500 | PF00244 | 0.551 |
LIG_14-3-3_CanoR_1 | 61 | 71 | PF00244 | 0.657 |
LIG_Actin_RPEL_3 | 219 | 238 | PF02755 | 0.365 |
LIG_Clathr_ClatBox_1 | 368 | 372 | PF01394 | 0.448 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.472 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.420 |
LIG_FHA_1 | 218 | 224 | PF00498 | 0.370 |
LIG_FHA_1 | 240 | 246 | PF00498 | 0.344 |
LIG_FHA_1 | 291 | 297 | PF00498 | 0.392 |
LIG_FHA_1 | 303 | 309 | PF00498 | 0.434 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.760 |
LIG_FHA_1 | 343 | 349 | PF00498 | 0.405 |
LIG_FHA_1 | 439 | 445 | PF00498 | 0.432 |
LIG_FHA_1 | 467 | 473 | PF00498 | 0.449 |
LIG_FHA_2 | 143 | 149 | PF00498 | 0.632 |
LIG_FHA_2 | 164 | 170 | PF00498 | 0.526 |
LIG_FHA_2 | 326 | 332 | PF00498 | 0.362 |
LIG_FHA_2 | 350 | 356 | PF00498 | 0.381 |
LIG_FHA_2 | 381 | 387 | PF00498 | 0.496 |
LIG_FHA_2 | 79 | 85 | PF00498 | 0.718 |
LIG_LIR_Apic_2 | 205 | 209 | PF02991 | 0.499 |
LIG_LIR_Apic_2 | 314 | 318 | PF02991 | 0.365 |
LIG_LIR_Apic_2 | 56 | 60 | PF02991 | 0.556 |
LIG_LIR_Gen_1 | 22 | 33 | PF02991 | 0.682 |
LIG_LIR_Gen_1 | 401 | 408 | PF02991 | 0.447 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.678 |
LIG_LIR_Nem_3 | 401 | 406 | PF02991 | 0.428 |
LIG_LIR_Nem_3 | 68 | 73 | PF02991 | 0.630 |
LIG_LYPXL_yS_3 | 70 | 73 | PF13949 | 0.635 |
LIG_NRBOX | 504 | 510 | PF00104 | 0.363 |
LIG_NRBOX | 519 | 525 | PF00104 | 0.355 |
LIG_SH2_CRK | 212 | 216 | PF00017 | 0.476 |
LIG_SH2_CRK | 25 | 29 | PF00017 | 0.668 |
LIG_SH2_CRK | 403 | 407 | PF00017 | 0.402 |
LIG_SH2_CRK | 57 | 61 | PF00017 | 0.715 |
LIG_SH2_NCK_1 | 267 | 271 | PF00017 | 0.404 |
LIG_SH2_NCK_1 | 403 | 407 | PF00017 | 0.421 |
LIG_SH2_STAP1 | 197 | 201 | PF00017 | 0.336 |
LIG_SH2_STAP1 | 25 | 29 | PF00017 | 0.668 |
LIG_SH2_STAT5 | 212 | 215 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 239 | 242 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 327 | 330 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 458 | 461 | PF00017 | 0.365 |
LIG_SH3_3 | 228 | 234 | PF00018 | 0.487 |
LIG_SH3_3 | 68 | 74 | PF00018 | 0.640 |
LIG_SH3_3 | 80 | 86 | PF00018 | 0.755 |
LIG_SUMO_SIM_anti_2 | 166 | 174 | PF11976 | 0.517 |
LIG_SUMO_SIM_anti_2 | 220 | 225 | PF11976 | 0.375 |
LIG_SUMO_SIM_par_1 | 217 | 222 | PF11976 | 0.380 |
LIG_SUMO_SIM_par_1 | 394 | 401 | PF11976 | 0.430 |
LIG_TRAF2_1 | 352 | 355 | PF00917 | 0.511 |
LIG_TYR_ITSM | 21 | 28 | PF00017 | 0.657 |
LIG_TYR_ITSM | 399 | 406 | PF00017 | 0.453 |
MOD_CDK_SPxxK_3 | 210 | 217 | PF00069 | 0.407 |
MOD_CK1_1 | 20 | 26 | PF00069 | 0.711 |
MOD_CK1_1 | 37 | 43 | PF00069 | 0.599 |
MOD_CK1_1 | 398 | 404 | PF00069 | 0.484 |
MOD_CK1_1 | 463 | 469 | PF00069 | 0.401 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.611 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.685 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.639 |
MOD_CK2_1 | 142 | 148 | PF00069 | 0.428 |
MOD_CK2_1 | 151 | 157 | PF00069 | 0.563 |
MOD_CK2_1 | 163 | 169 | PF00069 | 0.521 |
MOD_CK2_1 | 349 | 355 | PF00069 | 0.383 |
MOD_CK2_1 | 380 | 386 | PF00069 | 0.512 |
MOD_CK2_1 | 78 | 84 | PF00069 | 0.754 |
MOD_Cter_Amidation | 490 | 493 | PF01082 | 0.486 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.612 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.631 |
MOD_GlcNHglycan | 393 | 396 | PF01048 | 0.461 |
MOD_GlcNHglycan | 408 | 411 | PF01048 | 0.657 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.677 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.668 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.534 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.390 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.679 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.346 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.564 |
MOD_GSK3_1 | 391 | 398 | PF00069 | 0.467 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.630 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.750 |
MOD_LATS_1 | 15 | 21 | PF00433 | 0.727 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.666 |
MOD_NEK2_1 | 191 | 196 | PF00069 | 0.354 |
MOD_NEK2_1 | 238 | 243 | PF00069 | 0.327 |
MOD_NEK2_1 | 258 | 263 | PF00069 | 0.209 |
MOD_NEK2_1 | 282 | 287 | PF00069 | 0.389 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.703 |
MOD_NEK2_1 | 391 | 396 | PF00069 | 0.467 |
MOD_NEK2_2 | 197 | 202 | PF00069 | 0.359 |
MOD_NEK2_2 | 395 | 400 | PF00069 | 0.335 |
MOD_PIKK_1 | 357 | 363 | PF00454 | 0.439 |
MOD_PKA_1 | 225 | 231 | PF00069 | 0.507 |
MOD_PKA_2 | 16 | 22 | PF00069 | 0.636 |
MOD_PKA_2 | 191 | 197 | PF00069 | 0.352 |
MOD_PKA_2 | 225 | 231 | PF00069 | 0.507 |
MOD_PKA_2 | 342 | 348 | PF00069 | 0.404 |
MOD_PKA_2 | 404 | 410 | PF00069 | 0.572 |
MOD_PKB_1 | 493 | 501 | PF00069 | 0.418 |
MOD_Plk_1 | 258 | 264 | PF00069 | 0.420 |
MOD_Plk_1 | 78 | 84 | PF00069 | 0.651 |
MOD_Plk_4 | 24 | 30 | PF00069 | 0.731 |
MOD_Plk_4 | 258 | 264 | PF00069 | 0.430 |
MOD_Plk_4 | 316 | 322 | PF00069 | 0.346 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.632 |
MOD_Plk_4 | 463 | 469 | PF00069 | 0.427 |
MOD_Plk_4 | 519 | 525 | PF00069 | 0.478 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.711 |
MOD_Plk_4 | 90 | 96 | PF00069 | 0.654 |
MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.447 |
MOD_ProDKin_1 | 20 | 26 | PF00069 | 0.712 |
MOD_ProDKin_1 | 210 | 216 | PF00069 | 0.399 |
MOD_ProDKin_1 | 330 | 336 | PF00069 | 0.384 |
MOD_ProDKin_1 | 349 | 355 | PF00069 | 0.358 |
MOD_ProDKin_1 | 65 | 71 | PF00069 | 0.686 |
MOD_ProDKin_1 | 96 | 102 | PF00069 | 0.588 |
MOD_SUMO_rev_2 | 156 | 165 | PF00179 | 0.387 |
TRG_DiLeu_BaEn_1 | 169 | 174 | PF01217 | 0.397 |
TRG_DiLeu_BaEn_1 | 259 | 264 | PF01217 | 0.512 |
TRG_DiLeu_BaLyEn_6 | 373 | 378 | PF01217 | 0.472 |
TRG_ENDOCYTIC_2 | 212 | 215 | PF00928 | 0.437 |
TRG_ENDOCYTIC_2 | 25 | 28 | PF00928 | 0.755 |
TRG_ENDOCYTIC_2 | 267 | 270 | PF00928 | 0.402 |
TRG_ENDOCYTIC_2 | 403 | 406 | PF00928 | 0.396 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.788 |
TRG_ER_diArg_1 | 191 | 193 | PF00400 | 0.358 |
TRG_ER_diArg_1 | 224 | 226 | PF00400 | 0.360 |
TRG_ER_diArg_1 | 296 | 298 | PF00400 | 0.372 |
TRG_ER_diArg_1 | 306 | 308 | PF00400 | 0.391 |
TRG_ER_diArg_1 | 493 | 496 | PF00400 | 0.455 |
TRG_ER_diArg_1 | 60 | 62 | PF00400 | 0.656 |
TRG_NES_CRM1_1 | 361 | 375 | PF08389 | 0.459 |
TRG_NLS_MonoExtC_3 | 491 | 496 | PF00514 | 0.479 |
TRG_Pf-PMV_PEXEL_1 | 217 | 222 | PF00026 | 0.364 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IGU4 | Leptomonas seymouri | 78% | 94% |
A0A0S4JSB1 | Bodo saltans | 57% | 100% |
A0A1X0NS86 | Trypanosomatidae | 68% | 100% |
A0A3Q8IDM7 | Leishmania donovani | 96% | 100% |
A0A422N6M4 | Trypanosoma rangeli | 63% | 100% |
A4HEW9 | Leishmania braziliensis | 88% | 100% |
A4I243 | Leishmania infantum | 96% | 100% |
C9ZRW1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 67% | 99% |
E9AY93 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5B995 | Trypanosoma cruzi | 65% | 100% |